Immunohistochemical Reactivity of the 14F7 Monoclonal Antibody Raised against N-Glycolyl GM3 Ganglioside in Some Benign and Malignant Skin Neoplasms.
about
Interferon-stimulated gene 15 (ISG15) is a trigger for tumorigenesis and metastasis of hepatocellular carcinomaMolecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles.Tissue Reactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Tumors of Neuroectodermal, Mesodermal, and Epithelial Origin.NGlycolylGM3/VSSP Vaccine in Metastatic Breast Cancer Patients: Results of Phase I/IIa Clinical Trial.Effect of vaccination with N-glycolyl GM3/VSSP vaccine by subcutaneous injection in patients with advanced cutaneous melanoma.Frequent co-expression of EGFR and NeuGcGM3 ganglioside in cancer: it's potential therapeutic implications.Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Primary Lymphoid Tumors and Lymph Node Metastasis.NGcGM3/VSSP vaccine as treatment for melanoma patients.Involvement of a non-human sialic Acid in human cancer.Prognostic Role of 14F7 Mab Immunoreactivity against N-Glycolyl GM3 Ganglioside in Colon Cancer.A shift from N-glycolyl- to N-acetyl-sialic acid in the GM3 ganglioside impairs tumor development in mouse lymphocytic leukemia cells.Recombinant AAV-mediated in vivo long-term expression and antitumour activity of an anti-ganglioside GM3(Neu5Gc) antibody.Immunoreactivity of the 14F7 Mab (Raised against N-Glycolyl GM3 Ganglioside) as a Positive Prognostic Factor in Non-Small-Cell Lung Cancer.Synergistic potentiation of the anti-metastatic effect of anti EGFR mAb by its combination with immunotherapies targeting the ganglioside NGcGM3.Immunorecognition of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Some Normal and Malignant Tissues from Genitourinary System
P2860
Q34483623-D1B27E9A-F289-44F6-A8AE-BCF56C563CD3Q35217621-5662E062-5864-442F-8A25-FC7EFE48FFA8Q35623519-E54A0302-B775-4FEA-A172-BBF6A05EA819Q36300070-267F5BA9-0651-4200-9DAA-96D0686C46AEQ36307886-820229C2-AEE1-43FC-81D9-1A3BFB215070Q37280403-E18E55BB-7DF6-4748-BD4C-16F2A40A4D6BQ37393097-2896E9F7-17D5-4493-BCEA-9BD27D2C5F73Q37514743-3FFE1D83-8593-42A9-87A4-DD00D36AEF4AQ37592596-D3C2584B-3BFB-492D-940C-8BA884DB338CQ37594945-E96BFDDD-53BB-405B-BFE3-8018C4FD3F51Q39172701-BC66C447-9D12-4CAB-94D7-B9B20A6A77EDQ40729252-6906C5EF-1B88-4B60-92EC-9438A088287EQ42560665-97113A1C-92F8-4FE0-9705-BF6959A29CBFQ55439726-E7C218FA-71C6-46EA-9B7C-09895FE9625AQ58690190-A22543EB-83E6-4587-A0B5-D30E04220624
P2860
Immunohistochemical Reactivity of the 14F7 Monoclonal Antibody Raised against N-Glycolyl GM3 Ganglioside in Some Benign and Malignant Skin Neoplasms.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Immunohistochemical Reactivity ...... and Malignant Skin Neoplasms.
@ast
Immunohistochemical Reactivity ...... and Malignant Skin Neoplasms.
@en
type
label
Immunohistochemical Reactivity ...... and Malignant Skin Neoplasms.
@ast
Immunohistochemical Reactivity ...... and Malignant Skin Neoplasms.
@en
prefLabel
Immunohistochemical Reactivity ...... and Malignant Skin Neoplasms.
@ast
Immunohistochemical Reactivity ...... and Malignant Skin Neoplasms.
@en
P2093
P2860
P356
P1433
P1476
Immunohistochemical Reactivity ...... and Malignant Skin Neoplasms.
@en
P2093
Adriana Carr
Charles E Rengifo
Enrique Rengifo
Mercedes Cedeño
Milagros Frómeta
Rancés Blanco
P2860
P304
P356
10.5402/2011/848909
P577
2011-04-10T00:00:00Z